Home

Mitoxantrone Hydrochloride

Mitoxantrone Hydrochloride

Specifications

70476-82-3CAS Number
274-619-1EC Number
1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochlorideIUPAC Name
C22H30Cl2N4O6Chemical Formula
517.4 g/molMolecular Weight
70476-82-3; Mitoxantrone hydrochloride; Mitoxantrone dihydrochloride; CL-232315; Onkotrone; DTXSID0045173; Mitozantrone hydrochloride; CL 232,315; U6USW86RD0; NSC-301739; CL 232315; DTXCID8025173; CHEBI:50727; 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthraquinone dihydrochloride; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-, dihydrochloride; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone dihydrochloride; NSC301739; Mitroxone; Neotalem; Pralifan; RefChem:55657; Mitoxantroni Hydrochloridum; Hydrochloride, Mitoxantrone; Dihydroxyanthracenedione Dihydrochloride; 1,3-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthracenedione Dihydrochloride; 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthroquinone Dihydrochloride; 274-619-1; Mitoxantrone HCl; Novantrone; Novantron; Mitoxantrone 2HCl; Mitoxantrone Dihcl; 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione dihydrochloride; Mitoxantrone (dihydrochloride); MITOXANTHRONE HYDROCHLORIDE; DHAD; MFCD00242943; mitozantrone dihydrochloride; 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride; 1,4-Dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinone dihydrochloride; Immunex; 9,10-Anthracenedione,1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-, dihydrochloride; Bisantrone; mitoxanthrone hcl; CCRIS 2592; HSDB 6543; NCGC00015693-02; EINECS 274-619-1; CAS-70476-82-3; UNII-U6USW86RD0; NSC 301739; Eslep; SR-01000076001; Novantron (TN); 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione dihydrochloride; Mitoxantrone hydrochloride; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione dihydrochloride; Prestwick_571; 1,4-dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinone 2hcl; 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione hydrochloride; Mitoxantrone hydrochloride [USAN:USP:JAN]; 70476-82-3 (HCl); Mitoxantron dihydrochloride; SCHEMBL3928; orb134620; Mitoxantrone hydrochloride CRS; SPECTRUM1503278; NSC 301739 dihydrochloride; orb1224183; orb1310885; CHEMBL1417019; SCHEMBL29366412; SCHEMBL29462659; GLXC-03046; HMS1569M11; HMS1922O21; HMS5081E11; HY-13502AR; dhaq dihydrochloride 65271-80-9; Tox21_110197; Tox21_500779; CCG-39938; EBC-00689; HY-13502A; s2485; Mitoxantrone hydrochloride (JAN/USP); AKOS015895228; Tox21_110197_1; AC-1591; FM61451; LP00779; MITOXANTRONE HYDROCHLORIDE [JAN]; MITOXANTRONE DIHYDROCHLORIDE [MI]; MITOXANTRONE HYDROCHLORIDE [HSDB]; MITOXANTRONE HYDROCHLORIDE [USAN]; NCGC00015693-09; NCGC00094116-01; NCGC00094116-02; NCGC00094116-03; NCGC00094116-04; NCGC00261464-01; AS-13162; Mitoxantrone (dihydrochloride) (Standard); MITOXANTRONE HYDROCHLORIDE [MART.]; MITOXANTRONE HYDROCHLORIDE [VANDF]; Mitoxantrone Hydrochloride - API Standards; MITOXANTRONE HYDROCHLORIDE [USP-RS]; MITOXANTRONE HYDROCHLORIDE [WHO-DD]; DB-055419; EU-0100779; M3110; M3379; Mitoxantrone Dihydrochloride (NSC 301739); NS00091303; SW196745-5; Mitoxantrone dihydrochloride, >=97% (HPLC); D02166; EN300-268139; M 6545; MITOXANTRONE HYDROCHLORIDE [EP IMPURITY]; MITOXANTRONE HYDROCHLORIDE [ORANGE BOOK]; MITOXANTRONE HYDROCHLORIDE [EP MONOGRAPH]; F036509; MITOXANTRONE HYDROCHLORIDE [USP MONOGRAPH]; SR-01000076001-1; SR-01000076001-8; Q27122209; Z2569867923; Mitoxantrone hydrochloride, European Pharmacopoeia (EP) Reference Standard; 1,4-dihydroxy-5,8-bis-[[2-(2-hydroxyethylamino)ethyl]amino]-anthraquinone dihydrochloride; 1,4-dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinonedihydrochloride; 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone dihydrochloride; Mitoxantrone hydrochloride, United States Pharmacopeia (USP) Reference Standard; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione dihydrochloride; 1,4-Dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione--hydrogen chloride (1/2)Synonyms